Gd(ABE-DTTA), a novel contrast agent, at the MRI-effective dose shows absence of deleterious physiological effects in dogs

Pharmacology

Volumn 77, Issue 4, 2006, Pages 188-194

  Ruzsics, Balázs ^a   Surányi, Pál ^a,d   Kiss, Pál ^a,d   Brott, Brigitta C ^b   Elgavish, Ada ^c,d   Saab Ismail, Nada H ^d   Simor, Tamás ^a,d   Elgavish, Gabriel A ^a,b,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Elgavish Paramagnetics Inc   (United States)

Author keywords

Gadolinium based contrast agent; Ischemic heart disease; Magnetic resonance imaging

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM N (2 BUTYRLOXYETHYL) N' (2 ETHYLOXYETHYL) N,N' BIS[N',N' BIS(CARBOXYMETHYL)ACETAMIDO] 1,2 ETHANEDIAMINE; ISOFLURANE; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ACCUMULATION; ELECTROLYTE BLOOD LEVEL; ENZYME ACTIVITY; ERYTHROCYTE; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; KIDNEY FUNCTION; LEUKOCYTE; LIVER FUNCTION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; AMYLASES; ANESTHETICS, INHALATION; ANIMALS; BLOOD PROTEINS; CONTRAST MEDIA; DOGS; DRUG EVALUATION, PRECLINICAL; ELECTROLYTES; ERYTHROCYTE COUNT; ISOFLURANE; KIDNEY FUNCTION TESTS; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MOLECULAR STRUCTURE; MYOCARDIAL ISCHEMIA; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; TIME FACTORS;

EID: 33748292908     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094864     Document Type: Article

References (25)

1. Rehr RB, Peshock RM, Malloy CR, et al: Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol 1986;57:864-868.
2. Lima JAC, Judd RM, Bazille A, et al: Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 1995;92:1117-1125.
3. Van Rossum AC, Visser FC, Van Eenige MJ, et al: Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol 1990;65:845-851.
4. Kim SK, Pohost GM, Elgavish GA: Fatty-acyl iminopolycarboxylates: lipophilic bifunctional contrast agents for NMR imaging. Magn Reson Med 1991;22:57-67.
5. Chu WJ, Simor T, Elgavish GA: In vivo characterization of Gd(BME-DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function. NMR Biomed 1997;10:87-92.
6. Kim SK, Pohost GM, Elgavish GA: Gadolinium complexes of [(myristoyloxy)propyl]die thylenetriaminetetraacetate: new lipophilic, fatty acyl conjugated NMR contrast agents. Bioconjug Chem 1992;3:20-26.
7. Kiss P, Simor T, Lénárd L, et al: Relaxivity of Gd(ABE-DTTA) increases with magnetic field strength up to 5T. A contrast agent for high field imaging (abstract). Proc Intl Soc Magn Reson Med, Honolulu, 2002, p 10.
8. Kiss P, Surányi P, Simor T, et al: In vivo T1 mapping of canine hearts using Gd(ABE-DTTA) in an ischemia-reperfusion model (abstract). Toronto, 2003.
9. Saab-Ismail NH, Simor T, Gaszner B, et al: Synthesis and in vivo evaluation of new contrast agents for cardiac MRI. J Med Chem 1999;42:2852-2861.
10. Simor T, Chu WJ, Johnson L, et al: In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd(BME-DTTA). Circulation 1995;92:3549-3559.
11. Chu WJ, Hetherington HP, Kuzniecky RI, et al: Lateralization of human temporal lobe epilepsy by 31P NMR spectroscopic imaging at 4.1 T. Neurology 1998;51:472-479.
12. Simor T, Gaszner B, Saab-Ismail NH, et al: Gd(ABE-DTTA)-enhanced high resolution cardiac MRI for the diagnosis of acute myocardial ischemia (abstract). Bologna, Monduzzi Editore, 1998.
13. Simor T, Gaszner B, Oshinski JN, et al: Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart. J Magn Reson Imaging 2005;21:536-545.
14. Surányi P, Kiss P, Brott BC, et al: Determining tissue kinetics of Gd(ABE-DTTA), an infarct-avid, persistent contrast-agent in canine myocardial infarction (abstract). Kyoto Proc Intl Soc Magn Reson Med 2004;12:1836.
15. Carr DH, Brown J, Bydder GM, et al: Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR Am J Roentgenol 1984;143:215-224.
16. Leander P, Allard M, Caille JM, Golman K: Early effect of gadopentetate and iodinated contrast media on rabbit kidneys. Invest Radiol 1992;27:922-926.
17. Topal A, Gul N, Ilcol Y, Gorgul OS: Hepatic effects of halothane, isoflurane or sevoflurane anaesthesia in dogs. J Vet Med A Physiol Pathol Clin Med 2003;50:530-533.
18. Boudreau R, Burbidge S, Sirr S, Loken MK: Comparison of the biodistribution of manganese-54 DTPA and gadolinium-153 DTPA in dogs. J Nucl Med, 1987;28:349-353.
19. Johnston D: Special considerations in interpreting liver function tests. Am Fam Physician 1999;59:2223-2230.
20. Oostenbroek R, Willems GM, Boumans ML, et al: Liver damage as a potential source of error in the estimation of myocardial infarct size from plasma creatine kinase activity. Cardiovasc Res 1985;19:113-119.
21. Kanaya N, Nakayama M, Fujita S, Namiki A: Comparison of the effects of sevoflurane, isoflurane and halothane on indocyanine green clearance. Br J Anaesth 1995;74:164-167.
22. Suttner SW, Schmidt CC, Boldt J, et al: Low-flow desflurane and sevoflurane anesthesia minimally affect hepatic integrity and function in elderly patients. Anesth Analg 2000; 91:206-212.
23. Healey C, Chapman R, Fleming K: Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1995;37:274-278.
24. Haber M, West AB, Haber AD, Reuben A: Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995;90:1250-1257.
25. Kim J, Sohn JH, Lee HL, et al: Clinical characteristics of acute toxic liver injury (in Korean). Korean J Hepatol 2004;10:125-134.